Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,857 | -111,483 | -77,720 | -50,795 | -24,063 |
| Depreciation Amortization | -137 | -379 | 428 | -32 | -192 |
| Accounts receivable | -58 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,305 | 2,215 | 1,037 | 1,216 | 185 |
| Other Working Capital | -765 | 3,502 | -105 | -3,803 | -433 |
| Other Operating Activity | 5,451 | 18,672 | 13,588 | 8,107 | 4,266 |
| Operating Cash Flow | $-13,061 | $-87,473 | $-62,772 | $-45,307 | $-20,237 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 38,027 | -186,857 | -12,702 | 43,940 | 21,322 |
| PPE Investments | -86 | -616 | -447 | -313 | -291 |
| Investing Cash Flow | $37,941 | $-187,473 | $-13,149 | $43,627 | $21,031 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 809 | 270,787 | 270,476 | 6 | 6 |
| Common Stock Repurchased | -5 | -1 | -1 | -1 | -1 |
| Other Financing Activity | -273 | 0 | 0 | -63 | 0 |
| Financing Cash Flow | $531 | $270,786 | $270,475 | $-58 | $5 |
| Beginning Cash Position | 52,750 | 56,910 | 56,910 | 56,910 | 56,910 |
| End Cash Position | 78,161 | 52,750 | 251,464 | 55,172 | 57,709 |
| Net Cash Flow | $25,411 | $-4,160 | $194,554 | $-1,738 | $799 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,061 | -87,473 | -62,772 | -45,307 | -20,237 |
| Capital Expenditure | -86 | -616 | -447 | -313 | -291 |
| Free Cash Flow | -13,147 | -88,089 | -63,219 | -45,620 | -20,528 |